These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Studies on the prothrombin complex, II. Behavior of prothrombin, factor VII, IX and X during column chromatography on anion exchangesRS]. Voss D. Hoppe Seylers Z Physiol Chem; 1967 Sep; 348(9):1172-8. PubMed ID: 5588277 [No Abstract] [Full Text] [Related]
3. Separation of blood coagulation factors II, VII, IX and X by gel filtration in the presence of dextran blue. Swart AC, Hemker HC. Biochim Biophys Acta; 1970 Dec 29; 222(3):692-5. PubMed ID: 5496498 [No Abstract] [Full Text] [Related]
4. [Studies on the prothrombin complex, I. Behavior of prothrombin, factor VII, IX and X on barium sulfate]. Voss D. Hoppe Seylers Z Physiol Chem; 1967 Sep 29; 348(9):1163-71. PubMed ID: 4968304 [No Abstract] [Full Text] [Related]
5. The influence of ethanol feeding on the activities of factors II, VII, VIII, IX and X in rats. Morland J, Holm T, Prydz H. Thromb Haemost; 1976 Dec 31; 36(3):532-6. PubMed ID: 1037150 [Abstract] [Full Text] [Related]
6. The inhibitor of prothrombin conversion in plasma of patients on oral anticoagulant treatment. Bertina RM, Westhoek-Kuipers ME, Alderkamp GH. Thromb Haemost; 1981 Jun 30; 45(3):237-41. PubMed ID: 7281102 [Abstract] [Full Text] [Related]
7. [Longitudinal study of factors X, IX, VIII, V, II and I in the first 6 months of life]. Duvina PL, Simoni MR, Pezzati M, Poggi G, Rosati C, Trampi F, Duvina G. Minerva Pediatr; 1987 May 31; 39(10):421-36. PubMed ID: 3116376 [No Abstract] [Full Text] [Related]
13. The adsorption of blood coagulation factors II, VII, IX and X from human plasma to aluminium hydroxide. Swart AC, Klaassen BH, Bloys-van Treslong-de, Hemker HC. Thromb Diath Haemorrh; 1972 Jul 31; 27(3):490-501. PubMed ID: 4662612 [No Abstract] [Full Text] [Related]
14. Structural abnormalities of the vitamin K-dependent clotting factors. Roberts HR, Griffith MJ, Braunstein KM, Lundblad RL. Prog Clin Biol Res; 1981 Jul 31; 72():85-102. PubMed ID: 7335651 [No Abstract] [Full Text] [Related]
16. Preparation and clinical use of factor IX concentrate PPSB according to Soulier. Haanen C, McShine RL, Kunst A. Vox Sang; 1969 Apr 31; 16(4):398-411. PubMed ID: 5800593 [No Abstract] [Full Text] [Related]
17. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety. Herring SW, Abildgaard C, Shitanishi KT, Harrison J, Gendler S, Heldebrant CM. J Lab Clin Med; 1993 Mar 31; 121(3):394-405. PubMed ID: 8445288 [Abstract] [Full Text] [Related]
18. [Production of various vitamin K-dependent coagulation factors by immunoadsorbent technics and their clinical application]. Takamiya O. Rinsho Byori; 1985 Feb 31; Spec No 61():119-23. PubMed ID: 3889420 [No Abstract] [Full Text] [Related]
19. Chromatography of human plasma on aminohexyl Sepharose: separation of factor VIII/vWf and behaviour of factors II, VII, IX and X and antithrombin III. Ruttyn Y, Brandin MP, Vijayalakshmi MA. J Chromatogr; 1989 Jul 21; 491(2):299-308. PubMed ID: 2509508 [Abstract] [Full Text] [Related]
20. Use of chromogenic peptide substrates in the determination of clotting factors II, VII, IX and X in normal plasma and in plasma of patients treated with oral anticoagulants. van Dieijen-Visser MP, van Wersch J, Brombacher PJ, Rosing J, Hemker HC, van Dieijen G. Haemostasis; 1982 Jul 21; 12(3):241-55. PubMed ID: 7141303 [Abstract] [Full Text] [Related] Page: [Next] [New Search]